A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

NCT05569759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Hepatitis

Interventions

DRUG: zetomipzomib
DRUG: placebo
DRUG: zetomipzomib in open-label extension

Sponsor

Kezar Life Sciences, Inc.